Back to 
Renaissance Technologies LLC
Renaissance Technologies LLC
PLX
Showing 0 of 2 quarters
Position history for Renaissance Technologies LLC's holdings in Protalix BioTherapeutics, Inc.
No. Renaissance Technologies exited its PLX position in Q4 2019. Its Q3 2019 13F listed 4,450,473 shares worth $913,000. Renaissance Technologies already held PLX in its Q3 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.